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Abstract
Introduction: As the COVID-19 pandemic ravages the world, nursing resources, and capacities play an essential role in
disease management. This literature review focuses on the central issues related to the nursing care of patients affected
by COVID-19.
Material and methods: This literature review was conducted with an extensive search of databases, including PubMed, Web
of Science (WOS), and Scopus, using the keywords “COVID19”, “2019-nCoV disease”, “2019 novel coronavirus infection”,
“Nurse”, “Nursing Care”, and “Nursing management.” The span of the literature search was between December 01, 2020, and
January 12, 2021. A total of 28 original and English-language articles were selected for inclusion in the review.
Results: Nursing interventions such as monitoring, oxygen therapy, and the use of Extra Corporeal Membrane
Oxygenation (ECMO) in the care of COVID-19 patients, caring for ICU patients with COVID-19, rehabilitation of
COVID-19 patients, nurses' experiences and barriers in the care of patients with COVID-19, and also the ethical challenges in the care of patients with COVID-19, were found to be valuable in managing COVID-19 patients.
Conclusion: Nurses have a pivotal role to play in the care of patients with COVID-19. Therefore, providing comprehensive and quality nursing care supported by experience and research is necessary to successfully reduce the length of
hospital stay and decrease the morbidity and mortality rates of COVID-19.
Keywords: 2019 novel coronavirus infection, COVID-19, Nursing Care, Nurse

1. Introduction

A

fter identifying several cases of unknown
pneumonia caused by a Coronavirus
variant, on December 8, 2019, in Wuhan, Hubei
Province, China, concerns were raised among
public health professionals about the spread of a
new disease in the world [1]. This particular
version of the coronaviruses was not known to
infect human beings in the past. However, it is
now identiﬁed as the infecting organism in some

patients for unknown reasons, leading to widespread autoimmune reactions in those affected.
The virus was also implicated in human to human
infections, ultimately leading to a global
pandemic [2]. Epidemiological studies in COVID19 patients have shown that the main route of
transmission is from person to person through
coughing or sneezing [3].
With more than 20 million nursing workforces
worldwide, nurses constitute the largest proportion of
health care workers (HCW) [4, 5], playing a pivotal role
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in the COVID-19 prevention, treatment, and rehabilitation. Considering that nurses work in different health
care settings within the community, their multiple
roles and responsibilities are crucial during the
COVID-19 pandemic. Therefore, nurses should be
well prepared to provide high quality, evidence-based,
and comprehensive care for COVID-19 patients [5, 6].
Although the COVID-19 pandemic is still raging
and lots of information regarding the trajectory,
treatment, prevention, and control are still unfolding,
it is necessary to collate some of the latest scientiﬁc
information pertinent to nursing management. This
literature review aims to comprehensively review the
literature focusing on the central issues related to the
nursing care of patients affected by COVID-19.

2. Material and methods
This literature review was conducted via online databases, such as PubMed, Web of Science (WOS), and
Scopus from December 1, 2020, to January 12, 2021.
Keywords used for the search were selected using
medical subject headings (MESH) and combined with
other target keywords included “COVID19”, “2019nCoV disease”, “2019 novel coronavirus infection”,
“Nurse,” “Nursing Care” and “Nursing management.”
In the study, all types of English-language published
articles that could potentially become useful for caring
for COVID-19 patients were evaluated and included.
The search was performed by two authors independently. Gray literature search was not included in the
review due to the uncertainty surrounding such a
novel disease condition and the exponential amount of
speculation that characterized the pandemic's early
stages. To achieve maximum search comprehensiveness, lists of references from eligible studies were
evaluated manually. In order to manage the data,
search results were entered into the EndNote X8 software. After removing duplicate studies, the titles, abstracts, and full texts of the eligible articles were
evaluated by two researchers independently. A total of
688 articles were obtained initially using database
searches. Then article titles and abstracts were
screened to eliminate duplicate studies, leading to the
exclusion of s 656 articles. Finally, full texts of selected
articles were reviewed, and 28 eligible journal articles
were ﬁnally included in the review from which data
were extracted for analysis (Fig. 1).

3. Results
3.1. Epidemiologic features of COVID-19
3.1.1. Prevalence of COVID-19
According to the World Health Organization, a
total of 88,387,352 conﬁrmed cases of COVID-19 had

BioMedicine
2021;11(3):5e14

been identiﬁed around the world by January 12,
2021, out of which 1,919,204 deaths have occurred.
The United States with 21,761,186 infected patients
(365,886 deaths), India with 10,450,284 cases (150,999
deaths), and Brazil with 8,013,708 cases (201,460
deaths), were among the countries reporting the
highest numbers of cases and mortality [7].
3.1.2. Clinical and epidemiologic features
Although it has been reported that one-ﬁfth of
individuals with COVID-19 remain asymptomatic
[8], patients with mild infections may have
nonspeciﬁc manifestations, such as fever, fatigue,
cough (with or without fever), anorexia, weakness,
myalgia, sore throat, shortness of breath, nasal
congestion, and headache. Other uncommon
symptoms such as nausea, vomiting, anosmia, dysgeusia, and diarrhea [2, 9, 10] have also been reported. In a recent meta-analysis, fever (78.8%),
cough (53.9%), malaise (37.9%), and fatigue (32.2%)
were listed as the most common clinical manifestations in patients with SARS-Cov2. The mean incubation period of the disease is reported to be 5.3
days [9]. Awareness of the incubation period has a
useful role to play in screening and effective
epidemiological control policies [11] for Covid-19.
3.1.3. Modes of Disease transmission
The main route of transmission of the virus is
respiratory droplets. The SARS-CoV-2 is released in
the respiratory tract when an infected person
coughs, sneezes, or talks. Typically, the droplets do
not travel beyond 26 feet and do not remain in the
air. The highest risk of transmission occurs when a
patient is symptomatic, although asymptomatic
transmission has been conﬁrmed [12]. Epidemiological studies have shown that the virus is transmitted from person to person through personal
contact or by touching an infected surface and then
touching the nose, mouth, and eyes. Initially, the
transmission of the disease through aerosols' release
was questionable [13], but currently, there is enough
data to conﬁrm the possibility of SARS_Cov2 being
released by aerosol-producing procedures [14].
Although the oral-fecal method is not the primary
method of transmission, it cannot be ignored
because the presence of SARS-CoV-2 in the feces
has been conﬁrmed. Coronaviruses have better
survivability at humidity above 30% and 25 C temperature. SARS-CoV-2 stays alive on surfaces such
as metal, glass, or plastic [15] mobile phones and
door handles [13] for up to 9 days. However, these
surfaces can be disinfected for 1 minute using
disinfection methods with 62-71% ethanol, 0.5%
hydrogen peroxide, or 0.1% sodium hypochlorite.
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Fig. 1. Flow diagram of study selection.

The use of hand sanitizers and the disinfection of
the environment and patient care equipment are
essential infection prevention and control strategies,
both within the hospital and in community settings
[2].
3.1.4. Age-dependent effects of COVID-19
The age distribution of affected hospitalized patients is mostly middle-aged people (people older
than 30 years) and older adults. Morbidity and
mortality rates are highest among older adult patients hospitalized in the intensive care unit (ICU).
The clinical manifestations in these patients progress more rapidly and often lead to severe respiratory failure (9). Also, it has been reported that up to
50.9% of COVID-19 patients had underlying diseases [16]. Evidence suggests that infection is rare in
children and is usually mild, and when children are
infected, about 18% of cases remain asymptomatic.
The most common symptoms of COVID-19 in children have been reported as fever (51.2%) and cough
(37%) [17].

3.1.5. Risk Factors for COVID-19 induced ARDS and
Progression to Death
As the prevalence and spread of COVID-19 increases worldwide, many more deaths are likely to
be recorded. Older adults and people with underlying diseases, such as respiratory and cardiovascular diseases, are at higher risk. Smoking and
obesity are associated with an increased risk of
death [18]. In Italy, the risk of death and disease
severity was higher in smokers and men than in
women [19]. A Recently published meta-analysis
reveals that chronic respiratory diseases, hypertension, cardiovascular disease, chronic kidney disease,
cerebrovascular disease, malignancy, diabetes, and
obesity are most typical risk factors COVID-19
severity [20]. [20]The most common complication in
patients with COVID-19, which causes high mortality, is acute respiratory distress syndrome (ARDS)
[21]. In one study, 45% of people who died from
COVID-19 were as a result of ARDS development
[22]. The most common symptom of COVID-19
patients with ARDS is shortness of breath. The risk
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factors associated with the development of ARDS
and progression from ARDS to death include older
age (>65 years), neutrophilia, organ and coagulation
dysfunction, and higher lactate dehydrogenase and
D-dimer [23]. Vitamin D deﬁciency has been proposed as a risk factor for ARDS development in
CIVID-19 patients. Vitamin D deﬁciency causes
more cellular inﬂammation and cytokine release
within 48 hours of the development of ARDS. Also,
a deﬁciency of thiamine and selenium increases the
risk of developing ARDS [24, 25]. Despite all the
risks factors mentioned above, the Italian healthcare
system's experience revealed that the increase in the
nurses' workload and the shortage of beds during
the COVID-19 pandemic increased the mortality
rate of the disease dramatically, underscoring the
need to train more HCW and provide adequate care
infrastructure in order to reduce morbidity and
mortality of COVID-19 [26].
3.1.6. Infection prevention measures in the hospital
setting
Today, millions of HCW, especially nurses, are in
the front-line of the global battle to treat COVID-19
patients and ﬂatten the curve of transmission. Reports from China show that about 3,300 HCW were
infected by February 2020, with at least 22 of them
dying by the end of March [27]. The results of a
recently published systematic review regarding the
global prevalence of infection and mortality from
COVID-19 among HCW showed that a total of
152 888 infections and 1413 deaths were reported
among HCWs during the early phases of the
pandemic [28]. The high number of cases and
deaths among HCW resulted in a severe shortage
of staff, and extreme fatigue and stress among
nurses, with the likelihood of weakening the immune system and subsequent increase in infection
rates [29]. With the increasing prevalence of this
disease, the lack of personal protective equipment
(PPE) had become a signiﬁcant concern for health
care providers, as it is the ﬁrst step in protecting
them [30]. The availability and use of appropriate
personal protective equipment (PPE) such as face
masks, eye protectors, protective clothing, and
body coverings, including shoes and safety goggles
[31, 2], are effective strategies used to prevent the
spread of infections among HCW. To wear protective cover, nurses need to tie their hair, hold it in
place, and remove watches and jewellery during
patient care to prevent contamination. To prevent
dehydration, it is essential for nurses to drink
water before wearing PPE and use the bathroom as
necessary. In the event of any contamination,
damage, or rupture of full-body clothing, the PPE
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must be replaced. Nurses should also replace
gloves when they get wet [31].
It is best to use N95 masks or surgical masks
during patient care procedures [32]. It has been
previously shown that the incidence rate of respiratory infections in HCW who wore a surgical mask
was twice as high as those who wore N95 masks [33,
34]. Comparatively, medical masks and N95 masks
did not differ in protecting HCW during
noneaerosol care. However, N95 should be used
during short-term aerosol-generating procedures
and high-risk care [35].
Given that protection against aerosols' larger
than 0.3 microns entry into N95 masks is unknown,
research data suggests that N95 masks are more
effective than surgical masks in preventing the
spread of infections, but this has not been deﬁnitively clariﬁed [36]. Patients whose care increases
aerosol generation's possibility should be placed in
isolation units, with all precautions taken to prevent infecting those who care for them, especially
nurses [14]. Nurses should avoid being infected by
contaminated secretions of patients during interventions such as assisting patients with a
nebulizer, chest physiotherapy, bronchoscopy,
tracheostomy, intubation, orotracheal suction,
manual ventilation before intubation, non-invasive
ventilation,
cardiopulmonary
resuscitation,
gastroscopy, and collection of laboratory samples
[14, 37]. Nurses should use PPE when collecting
samples from COVID-19 patients or suspected
patients, and then the samples should be sent
separately in non-perforated bags, along with the
laboratory requisition forms [37]. Preferably,
immediately after the end of each day, all equipment, ﬂoors, nursing stations, and other areas of
hospital wards must be disinfected with 2 or 3%
hydrogen peroxide [38].
3.2. Nursing Care of Patients with COVID-19
3.2.1. Monitoring
Precise and continuous monitoring of COVID-19
patients by nurses is crucial for recognizing patients'
deterioration and occurrence of any potential complications. The patient's vital signs should be
monitored continuously, with particular attention
paid to respiration rate, oxygen saturation (SPO2),
and changes in consciousness level. Clinically,
common and signiﬁcant symptoms of COVID-19
such as cough, shortness of breath, fever, sputum,
and chest tightness, should be monitored. If needed,
the patient's arterial blood gas (ABG) results should
be evaluated at frequent intervals [39]. Patients'
temperature should be checked, and any

temperature greater than 37.3 C should be reported
and followed up. Surgical masks should be offered
immediately to patients with symptoms of cough
and sneezing. Liquids or IV ﬂuid therapy should be
used to prevent dehydration and worsening respiratory status when appropriate. As a result of the
anorexia experienced by these patients and the need
to strengthen their immunity, their diet should
contain a balanced ratio of protein, carbohydrates,
vitamins, and minerals [40]. Although continuous
monitoring of the ' patients respiratory system is
vital, nurses should not neglect other organs' or
forget to assess other body systems.
3.2.2. Oxygen therapy and ECMO in care of COVID19 patients
Acute hypoxemic respiratory failure or ARDS is
the most common and severe complication of
COVID-19, which requires oxygen and ventilation
therapy. For patients with mild or moderate respiratory problems and hypoxemia, oxygen therapy
using a nasal cannula, simple face mask, or reservoir
mask may be enough. The appropriate ﬂow rate of
oxygen should be determined based on the patient's
condition. If oxygen therapy does not achieve the
oxygen saturation target range, nurses should
investigate the potential causes and use other oxygen delivery devices or methods [41, 2]. Extracorporeal Membrane Oxygenation (ECMO) may be an
effective modality for COVID-19-related acute
hypoxemic respiratory failure [42]. Given the effectiveness of ECMO in Middle East Respiratory Syndrome Coronavirus (MERS-COV) patients with
ARDS, this method appears to be effective in
COVID-19, but the data are inconsistent. Contrary
to the recommendations for using ECMO in
COVID-19 patients with ARDS [43], this treatment
was not effective in some cases [44]. Care of patients
receiving oxygen therapy using different devices is
brieﬂy shown in Table 1.
3.2.3. Caring for ICU patients with COVID-19
In the ICU, two nurses per patient must perform
proper safe care and isolation of patients with
COVID-19 [37]. In COVID-19 patients with ARDS, a
high-ﬂow nasal cannula (HFNC) and non-invasive
ventilation (NIV) are useful in maintaining positive
end-expiratory pressure (PEEP) and preventing
alveolar collapse. Prone positioning combined with
low tidal volume (6 ml/kg of ideal body weight) and
neuromuscular blocking agents improves ARDS
patients' oxygen therapy [45, 46]. A systematic review revealed prone positioning could signiﬁcantly
improve the oxygenation and perfusion in COVID19 patients [47]. Besides, prone positioning is

A EMAMI ZEYDI
COVID-19 FROM A NURSING PERSPECTIVE

9

recommended for oxygen improvement in mechanically ventilated COVID-19 patients with severe
ARDS [48]. Patients who are ventilated and placed
in the prone position are at risk for complications
such as endotracheal tube displacement, limited
access to the venous route, bruising around the
mouth, bedsores, possible kinking of catheters,
periorbital and facial edema, increased oral secretions, and skin damage [46]. In patients predisposed
to pressure injuries, nurses must perform continuous risk assessments and change patients' positions at regular intervals. [49]. Simultaneously, the
nurse should examine the patient for bed sores and
prevent falls, tube slipping, and eye damage caused
by pressure, skin and mouth damage, and other
complications [2]. A major limitation in patients in
the prone position is a potential difﬁculty encountered if the patient requires to be intubated and the
requirement for 3 to 5 people to participate in the
procedure [50]. Restriction of ﬂuid intake is effective
in relieving pulmonary edema [43]. If the patient has
ARDS or has the necessary criteria, the patient may
require invasive mechanical ventilation. [2]
Although there is no single ‘Silver Bullet’ to cure
COVID-19, a clinical expert panel called the frontline COVID-19 Critical Care Alliance proposed a
promising management protocol (MATHþ: a
combination of intravenous methylprednisolone,
high dose intravenous ascorbic acid, thiamine, full
anticoagulation with heparin and other co-interventions) as a life-saving approach in critically ill
or other COVID-19 patients [51, 52]. However, this
treatment protocol should be investigated and
conﬁrmed in future studies in critical care units.
The use of a closed airway suction device,
convalescent plasma therapy for severe and critically ill patients, the use of lung-protective strategy
in patients with ARDS, avoidance of excessive
PEEP, ﬂuid resuscitation with crystalloids, monitoring of signs of secondary infection in patients
admitted to ICU> 48 h, and early nutrition therapy
during 24e48 hours after admission are other
recommended interventions in ICU COVID-19
patients [53].
3.2.4. Other Nursing Care and rehabilitation of
COVID-19 patients
As the number of new COVID-19 infections is
increasing daily, nurses must isolate patients and
prevent virus spread when transferring these patients between wards. Nurses must consider ﬁve
principles when transferring patients; these include
recognizing patients in the acute phase of the
disease, the nurses' safety, protecting others, availability of emergency treatment measures, and the
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Table 1. Oxygen therapy in the care of COVID-19 patients.
Oxygen therapy
methods

Rate

Low Flow Oxygen Delivery Devices
Nasal cannula
1-6 liter/min
Simple (Hudson) 5-10 liter/min
Mask
Venturi mask
2-15 liter/min
Reservoir bag
15 liter/min
(non-rebreather
mask)

High Flow Oxygen Delivery Devices
Facial mask with Oxygen ﬂow rate does
Venturi valve
not depend on minutes.
High Flow Nasal 1-60 liter/min
Cannula

Non-Invasive Ventilation
Continuous positive airway pressure (CPAP)
Bilevel positive airway pressure (BiPAP)

Extracorporeal membrane oxygenation (ECMO)

FiO2

24-44%
35-60%
24-60%
85-90%

24-30%
24-70%

Nursing Care
 Provide accurate information on oxygen delivery devices to engage the
patient before oxygen therapy.
 Use a low dose sedative. Use a proper nasal catheter based on the diameter of the patient's nasal cavity.
 Use decompression plaster to prevent facial skin damage and head strap
tightness.
 Adjust the water level in the humidiﬁer chamber.
 Control ﬂow rate, FiO2, and water temperature based on the patient's
respiratory needs.
 Record and report the following to the doctor: hemodynamic instability,
respiratory distress, hypoxemia persists despite oxygen therapy, deterioration of consciousness, breathing rate more than 40 cycles per minute,
signiﬁcant sputum [75].
✓ Ordinary oxygen therapy devices that carry dry oxygen cause mask
discomfort, dry nose and mouth, eye irritation, nasal and eye damage,
bloating, and aspiration. Adequate moisture supply through HFNC can
prevent airway dryness and inﬂammatory response due to mucosal dryness [75].
✓ Patients' sputum and secretions should be cleaned using tissue paper and
disposed of in a chlorine-containing disinfectant (2500 mg/L).
✓ Patients' secretions can be disposed of using an oral mucus extractor or
suctioning tube in a chlorine-containing disinfectant collector (2500 mg/L)
[39].
 Patients who receive CPAP/BiPAP through the nose may complain of
nasal and pharyngeal discomfort. Therefore, it is possible to reduce the
side effects of ventilation by adding sufﬁcient warm humidity.
 Low ambient temperature and humidity in the circuit may cause water to
accumulate in the nostrils and interfere with the patient's sleep, so nurses
should consider factors affecting humidity, such as the patient's breathing
pattern, the ﬂow delivered to the HFNC, and note the type of device and
the appropriate position of the nasal cannula [76].
✓ Nurses need to quickly diagnose any neurological changes, such as: increase in the size of the pupil, change in skin color and temperature,
decrease in oxygen saturation, hypotension or hypertension, and take
appropriate actions.
✓ Nurses should examine patients under ECMO for colds, blemishes, and
pale skin.
✓ If there is any ischemia, these patients pulses must be monitored every 4
hours or less and, inform the doctor immediately and take the necessary
measures [77, 2].
✓ Nurses should evaluate COVID-19 patients on ECMO for erythema, pus,
integrity and dressing efﬁciency, canula constancy, ecchymosis in the
abdomen and inguinal areas, hypotension, and acute anemia.
✓ The patients' body temperature should be assessed for fever for early
diagnosis of infection.
✓ The use of steroids in ARDS and adrenal insufﬁciency, body temperature
control, and blood transfusion following cardiac surgery can be effective
in reducing the risk of infection in patients under ECMO [78].
✓ Patients with COVID-19 who are in ICU and are supported by ECMO are
at risk for bed sores due to hemodynamic instability and high doses of
multiple vasopressors, which lead to decreased tissue perfusion. Therefore, it is necessary to provide special skin care in patients with COVID-19
who are supported by ECMO [78].

possibility of infecting others after the patient's
transfer is completed. During patient transfer, a
physician or nurse who can manage emergency
conditions should accompany the patient. The patient needs constant monitoring of blood pressure,

pulse, pulse oximetry, and CO2 levels and may
require a deﬁbrillator. Nurses must wear N95 masks
and PPE to ensure their safety, and the patients
must wear surgical masks, if possible. During patient transport, a speciﬁc route must be planned,

and after the transfer, the route must be disinfected
and the nurses' protective clothing replaced [54].
With the increasing spread of the COVID-19
pandemic and the high number of patients admitted
to the ICU, patients who survive and are discharged
from the ICU need rehabilitation. Rehabilitation is a
vital part of patient-centered care in response to the
COVID-19 crises and plays an essential role in
accelerating recovery after discharge from the ICU
[55]. These patients may develop post-ICU syndrome and complications that may include immobility, venous thromboembolism, delirium [56],
depression [57], post-traumatic stress disorder
(PTSD) [58], and anxiety [59]. Rehabilitation should
be done in short-term, medium, and long-term
programs for patients and their families. Maintaining an active relationship between nurses and patients' families plays an essential role in providing
adequate care during the rehabilitation process.
After discharge from the ICU, patients may be
negatively impacted by prolonged use of sedatives,
immobility, mechanical ventilation, and delirium,
and may depend on personal and daily care from
HCW. Many surviving COVID-19 patients need to
be admitted to a rehabilitation centre to improve
their functioning and be prepared to re-enter society [55].
3.3. Nurses' experiences in the Care of Patients with
COVID-19
Paying attention to nurses' experiences in the
COVID-19 pandemic can provide the best foundation for better crisis management in the future.
Nurses' experiences during the Covid-19 Pandemic
can be evaluated in various positive and negative
dimensions. Nurses' negative experiences were
usually related to difﬁculties in coping with
increased work and family demands during the
pandemic. As the pandemic ravages the world,
management issues were among the most critical
negative experiences of nurses. These include
nursing staff shortages, long shifts, scarcity of resources, and PPE shortages [60, 61]. Long shifts in
the hospital, being away from family, and end-oflife care can cause emotional problems among
nurses and other HCW [62, 61]. In two qualitative
studies from Turkey [63] and Iran [64], nurses
experienced various psychological distress during
the care of COVID-19 patients.
In contrast, nurses' positive experiences resulted
from the nursing profession's positive contributions during the COVID-19 pandemic. Nurses'
spoke of positive comments and more respect from
other people for their sacriﬁces. This pandemic has
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led to a better appreciation of the nursing profession's contributions in managing complex public health problems and patient recovery. These
positive developments have provided new opportunities for developing the nursing profession [61].
Strengthening the spirit of cooperation, pride in
oneself as a committed nurse, strengthening selfconﬁdence in caring for patients, and public support for nurses and other HCW, have been other
positive experiences of nurses during the COVID19 pandemic [60].
3.4. Nursing management during the COVID-19
Pandemic
As the COVID-19 crisis continues, nurse managers must make quick, creative, practical, and
useful decisions and use appropriate methods to
engage patients and their families during the disease process. Nursing personnel administrators
must provide the appropriate emotional and
physical support for nurses to enable them to meet
the increased expectations placed on them [65].
Nurse managers should also develop management
plans to provide high quality, safe, and cost-effective care [66]. The main aspects in human resource
management during this crisis include: clarifying
human
resource
structures,
standardizing
communication procedures, securing an adequate
number of HCW and other staff, restricting highrisk procedures/behaviours, and developing ﬂexible shifts for nurses [67]. Creating positive interactions between patients, families, and nurses to
provide care can play a vital role in managing
COVID-19 [65]. Appropriate instruction and
interaction after discharge to provide relevant patients' care needs such as medication adherence,
diet, psychological counseling, and observance of
care standards are necessary and can be achieved
by Tele-nursing. Tele-nursing improves the quality
of care and treatment outcomes, controls treatment
costs, reduces the need for emergency room visits,
and encourages patient and family involvement in
care decisions to achieve a high self-management
level [68].
3.5. Nurses' barriers to caring for patients with
COVID-19
There are several barriers for nurses in caring for
COVID-19 patients. Most important of these are
limited and ambiguous information about COVID19 and inadequate support for HCW, such as a lack
of facilities and PPE. Also, concerns about their
family safety and emotional and psychological stress
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were other barriers reported by nurses as they cared
for COVID-19 patients [69].

while ensuring that nursing staff is protected while
caring for patients.

3.6. Ethical Challenges in the Care of Patients with
COVID-19

Acknowledgments

With the spread of COVID-19, many patients are
admitted into hospitals for care. Lack of sufﬁcient
medical equipment, PPE, nursing and medical staff
shortages, and bedding have created ethical challenges for nurses and other HCW [70]. Due to
insufﬁcient and inadequate medical resources,
medical staff had to impose restrictions on Italy's
patient care [70]. For example, younger people may
be preferred for admission into ICU and mechanical
ventilation [71] over older patients. In the United
States, do-not-attempt-resuscitate (DNAR) has been
recommended for some patients due to a shortage
of respiratory support devices, ICU spaces, and PPE
[72]. Another challenge in patients with COVID-19
is cardiopulmonary resuscitation (CPR) [73]. It may
take up to 10 minutes to enter the patient's room,
remove the clothing, and prepare to resuscitate the
patient. The same delay in CPR reduces the possibility of survival of a patient with COVID-19 by up
to 10%. The lack of sufﬁcient equipment and medical personnel, the implementation or non-implementation of CPR on patients over 80 who have
undergone cardiac arrest are considered some of the
major ethical challenges [71] encountered during
the care of COVID-19 patients. Therefore, resource
allocation during a pandemic should be based on
the maximum use of limited resources, the equitable treatment of different individuals, and
resource prioritization of care according to how
critical the patients' needs are [74].

4. Conclusion
The global prevalence of COVID-19 requires
nurses' active participation as the most extensive
and primary professionals at the forefront of the
ﬁght against the pandemic. The ﬁght against
COVID-19 requires a combination of care based on
scientiﬁc evidence, education and information
sharing, public health, and sound policy. Nurses
have a pivotal role in caring for patients with
COVID-19. Providing comprehensive nursing care
of the highest quality, supported by experience and
research, can successfully reduce patients' length of
hospital stay, reduce morbidity and mortality rates
of the disease, and promote patients' recovery rate.
As the COVID-19 crisis rages on, nurse managers
should also develop management plans to provide
high-quality, safe, and cost-effective care to patients
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